文献速递艾滋病与性传播感染

血液表观遗传衰老生物标志物对控制良好HIV-1感染者的预后价值

Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection.
PubMed 文献 · Clin Infect Dis · 2026-01-01

本研究为纵向观察队列,纳入216例持续病毒学抑制(中位6.5年)的HIV感染者,评估8种表观遗传时钟与10年不良事件的关系。结果显示Horvath时钟阳性EAA与衰老相关事件风险升高50%相关,PC-GrimAge、GrimAge V1-V2及Hannum时钟阳性EAA与SNAEs风险增加2倍以上相关,GrimAge V1-V2阳性EAA与全因死亡风险增加4倍相关。

要点

  • GrimAge与PC-GrimAge阳性EAA与控制良好HIV感染者不良结局风险增加相关。
  • Horvath时钟阳性EAA与衰老相关事件风险升高50%相关。
  • 所有死亡者(n=17)基线DunedinPACE值均>1。

核心结论

  • 在控制良好的HIV感染者中,GrimAge和PC-GrimAge与不良结局风险增加相关。
  • 这些表观遗传衰老标志物可能作为长期健康风险生物标志物,需在更大队列中验证。

研究设计与样本

  • 纵向观察队列,纳入216例持续病毒学抑制(中位6.5年)的HIV感染者,来自DUAL-GESIDA试验和La Paz Aging Cohort(西班牙)。
  • 基线评估血液DNA甲基化以计算8种表观遗传时钟、其主成分衍生指标及端粒长度估计值。
  • 随访10年记录AIDS、严重非AIDS事件(SNAEs)和衰老相关事件,采用多变量Cox模型分析EAA与结局的关联。

主要发现

  • Horvath时钟阳性EAA与衰老相关事件风险升高50%相关。
  • PC-GrimAge、GrimAge V1-V2及Hannum时钟阳性EAA与SNAEs风险增加2倍以上相关。
  • PC-GrimAge和PhenoAge阳性EAA与非AIDS癌症风险增加相关。
  • GrimAge V1-V2阳性EAA与全因死亡风险增加4倍相关;所有死亡者(n=17)基线DunedinPACE值>1。

临床怎么用

  • 对于病毒学抑制的HIV感染者,可考虑检测GrimAge或PC-GrimAge等表观遗传时钟以识别不良结局高风险个体。
  • DunedinPACE>1可能提示死亡风险升高,但需进一步验证。

局限性

  • 本研究为初步研究,样本量有限(216例),需在更大队列中验证。
  • 复合终点和心血管事件未见关联,表观遗传标志物的预后价值限于特定结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epigenetic age acceleration (EAA) predicts morbidity and mortality in the general population, but its prognostic utility in people with human immunodeficiency virus (HIV) (PWH) on suppressive antiretroviral therapy remains unclear. METHODS: Longitudinal observational cohort of 216 PWH with sustained virological suppression (median 6.5 years) recruited from the DUAL-GESIDA trial and La Paz Aging Cohort (Spain). Baseline blood DNA methylation was assessed to evaluate 8 epigenetic clocks, their principal-component (PC) derivatives, and the telomere length estimator. Over 10 years, we recorded AIDS, serious non-AIDS (SNAEs), and aging-related events. Associations between EAA and outcomes were evaluated by multivariate Cox models. RESULTS: One hundred five participants experienced ≥ 1 event, 162 events recorded in total (1 AIDS event, 65 SNAEs, and 96 aging-related events). A positive EAA by Horvath's clock was associated with a 50% higher risk of aging-related events. Participants with positive EAA according to PC-GrimAge, GrimAge V1-V2, as well as Hannum´s clock experienced more than 2-fold increased risk of SNAEs. Positive EAA by PC-GrimAge and PhenoAge was associated with an increased risk of non-AIDS cancer. Additionally, positive EAA according to GrimAge V1-V2 was linked to a 4-fold increase in all-cause mortality risk. All individuals who died (n = 17) had a baseline DunedinPACE value >1. No associations were found for the composite endpoint or cardiovascular events. CONCLUSIONS: In this preliminary study, GrimAge and PC-GrimAge were associated with increased risk of adverse outcomes in people with well-controlled HIV infection. These findings suggest their potential as long-term health-risk biomarkers, warranting validation in larger cohorts.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Martínez-Martín P, Esteban-Cantos A, Jurado F, et al. Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection. Clin Infect Dis. 2026. PMID: 41024391. doi:10.1093/cid/ciaf537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。